Activation and identification of five clusters for secondary metabolites in Streptomyces albusJ1074

Microbial Biotechnology
2014.0

Abstract

<jats:title>Summary</jats:title><jats:p><jats:styled-content style="fixed-case"><jats:italic>S</jats:italic></jats:styled-content><jats:italic>treptomyces albus</jats:italic> <jats:styled-content style="fixed-case">J</jats:styled-content>1074 is a streptomycete strain widely used as a host for expression of secondary metabolite gene clusters. Bioinformatic analysis of the genome of this organism predicts the presence of 27 gene clusters for secondary metabolites. We have used three different strategies for the activation of some of these silent/cryptic gene clusters in <jats:styled-content style="fixed-case"><jats:italic>S</jats:italic></jats:styled-content><jats:italic>. albus</jats:italic> <jats:styled-content style="fixed-case">J</jats:styled-content>1074: two hybrid polyketide‐non‐ribosomal peptides (<jats:styled-content style="fixed-case">PK‐NRP</jats:styled-content>) (antimycin and 6‐<jats:italic>epi</jats:italic>‐alteramides), a type <jats:styled-content style="fixed-case">I PK</jats:styled-content> (candicidin), a non‐ribosomal peptides (<jats:styled-content style="fixed-case">NRP</jats:styled-content>) (indigoidine) and glycosylated compounds (paulomycins). By insertion of a strong and constitutive promoter in front of selected genes of two clusters, production of the blue pigment indigoidine and of two novel members of the polycyclic tetramate macrolactam family (6‐<jats:italic>epi</jats:italic>‐alteramides <jats:styled-content style="fixed-case">A</jats:styled-content> and <jats:styled-content style="fixed-case">B</jats:styled-content>) was activated. Overexpression of positive regulatory genes from the same organism also activated the biosynthesis of 6‐<jats:italic>epi</jats:italic>‐alteramides and heterologous expression of the regulatory gene <jats:italic>pim</jats:italic><jats:styled-content style="fixed-case"><jats:italic>M</jats:italic></jats:styled-content> of the pimaricin cluster activated the simultaneous production of candicidins and antimycins, suggesting some kind of cross‐regulation between both clusters. A cluster for glycosylated compounds (paulomycins) was also identified by comparison of the high‐performance liquid chromatography profiles of the wild‐type strain with that of a mutant in which two key enzymes of the cluster were simultaneously deleted.

Knowledge Graph

Similar Paper

Activation and identification of five clusters for secondary metabolites in <scp><i>S</i></scp><i>treptomyces albus</i> <scp>J</scp>1074
Microbial Biotechnology 2014.0
Generation of a cluster-free Streptomyces albus chassis strains for improved heterologous expression of secondary metabolite clusters
Metabolic Engineering 2018.0
Discovery of a Cryptic Antifungal Compound from <i>Streptomyces albus</i> J1074 Using High-Throughput Elicitor Screens
Journal of the American Chemical Society 2017.0
New Deferoxamine Glycoconjugates Produced upon Overexpression of Pathway-Specific Regulatory Gene in the Marine Sponge-Derived Streptomyces albus PVA94-07
Molecules 2016.0
Uncovering production of specialized metabolites by Streptomyces argillaceus: Activation of cryptic biosynthesis gene clusters using nutritional and genetic approaches
PLOS ONE 2018.0
Uncovering production of specialized metabolites by Streptomyces argillaceus: Activation of cryptic biosynthesis gene clusters using nutritional and genetic approaches
PLOS ONE 2018.0
Natural Product Discovery through Improved Functional Metagenomics in <i>Streptomyces</i>
Journal of the American Chemical Society 2016.0
Natural Product Discovery through Improved Functional Metagenomics in <i>Streptomyces</i>
Journal of the American Chemical Society 2016.0
The complete genome sequence of Streptomyces albolongus YIM 101047, the producer of novel bafilomycins and odoriferous sesquiterpenoids
Journal of Biotechnology 2017.0
Insights into naturally minimised Streptomyces albus J1074 genome
BMC Genomics 2014.0